5 stars in Apple and Google store


Brexpiprazole is an antipsychotic forming part of the class of drugs known as atypical antipsychotics. This group of antipsychotics primarily works by reducing the effects of naturally occurring substances in the brain, such as dopamine and serotonin. Brexpiprazole is prescribed to treat depression and schizophrenia.

Brexpiprazole and the benefit of DNA analysis

The rate at which brexpiprazole is processed within your body varies from one individual to another. This means that the efficacy and side effects of brexpiprazole can be predicted to some extent on the basis of your genes. Preventive DNA analysis can therefore be an important tool in optimising your medication.

Brexpiprazole and the enzyme CYP2D6

Brexpiprazole is processed to a large extent by the enzyme CYP2D6. The activity of this enzyme can vary considerably depending on your genetic predisposition, which means the efficacy of brexpiprazole can also differ from person to person.

Information about your genetic predisposition may therefore provide grounds for extra vigilance in relation to a treatment with brexpiprazole.

Read more about CYP2D6 enzyme »

Also known as

Rexulti, RXULTI
logo iGene

© Copyright 2023 - iGene | Disclaimer | General Terms and Conditions | Privacy policy | Cookiepolicy
iGene / Oude Haven 102 / 6511 XH Nijmegen / +31 (0)10 310 4200 info@igene.eu